Harnessing immune cells' adaptability to design an effective HIV vaccine

In infected individuals, HIV mutates rapidly to escape recognition by immune cells. This process of continuous evolution is the main obstacle to natural immunity and the development of an effective vaccine. A new study published by Cell Press in the March 21 issue of the journal Immunity reveals that the immune system has the capacity to adapt such that it can recognize mutations in HIV. The findings suggest that our immune cells' adaptability could be harnessed to help in the fight against AIDS.

An international collaboration between research groups in France, England, Japan, and Australia discovered that immune cells from certain infected individuals were able to recognize HIV mutants. Researchers found that the immune cells' ability to recognize such mutant forms of the virus was associated with a protective response against HIV. This discovery begs the question: if mutant HIV can be recognized by immune cells, how then does HIV often escape immune detection? The researchers explain that the answer lies in HIV's ability to conceal itself from altogether. It does so by blocking infected cells from breaking down its and from then displaying them on the cells' surface to alert the immune system.

"Using a spectrum of advanced immune profiling techniques, our work illustrates the sophisticated mechanisms that underlie the continuous competition, or 'molecular arms race,' between immune cells and HIV," says senior author Dr. Victor Appay, of Hôpital Pitié-Salpêtrière in Paris. "Overall, our study reveals the intricacies of immune cell efficacy against HIV."

Although immune cells not be able to recognize every mutant HIV, a vaccine that stimulates that recognize certain key mutant forms of the virus may be effective against viral infection and the development of AIDS.

More information: Immunity, Ladell et al.: "A molecular basis for the control of pre-immune escape variants by HIV-specific CD8+ T-cells." dx.doi.org/10.1016/j.immuni.2012.11.021

Related Stories

Exhausted B cells hamper immune response to HIV

Jul 14, 2008

Recent studies have shown that HIV causes a vigorous and prolonged immune response that eventually leads to the exhaustion of key immune system cells--CD4+ and CD8+ T-cells--that target HIV. These tired cells become less ...

Exhausted B cells fail to fight HIV

Jul 14, 2008

HIV tires out the cells that produce virus-fighting proteins known as antibodies, according to a human study that will be published online July 14 in the Journal of Experimental Medicine.

How HIV vaccine might have increased odds of infection

Nov 03, 2008

In September 2007, a phase II HIV-1 vaccine trial was abruptly halted when researchers found that the vaccine may have promoted, rather than prevented, HIV infection. A new study by a team of researchers at the Montpellier ...

Recommended for you

Expelled DNA that traps toxins may backfire in obese

Jun 18, 2013

(Medical Xpress)—The body's most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight and others at risk for cancer, diabetes and chronic ...

Managing seasonal allergies

Jun 17, 2013

(HealthDay)—Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.

Researchers investigating the mystery of a tiny 'sin'

Jun 13, 2013

When a strain of bacteria invades a human body, the immune system responds by generating antibodies to neutralize the threat. However, during subsequent infections by a similar bacterium, the immune system ...

Herpes virus exploits immune response to bolster infection

Jun 06, 2013

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an ...

User comments

More news stories

Validating maps of the brain's resting state

Kick back and shut your eyes. Now stop thinking. You have just put your brain into what neuroscientists call its resting state. What the brain is doing when an individual is not focused on the outside world ...

Antioxidant shows promise in Parkinson's disease

Diapocynin, a synthetic molecule derived from a naturally occurring compound (apocynin), has been found to protect neurobehavioral function in mice with Parkinson's Disease symptoms by preventing deficits in motor coordination.

No danger of cancer through gene therapy virus

In fall 2012, the European Medicines Agency (EMA) approved the modified adeno-associated virus AAV-LPL S447X as the first ever gene therapy for clinical use in the Western world. uniQure, a Dutch biotech company, had developed ...